Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
23.85 M USD
6.51 M USD
1.27 M
About Redhill Biopharma Ltd.
Sector
CEO
Dror Ben-Asher
Headquarters
Tel Aviv
Website
Founded
2009
FIGI
BBG003RY91S7
RedHill Biopharma Ltd. develops medicines for gastrointestinal and infectious diseases. It operates through Commercial Operations, and the Research and Development segments. The Commercial Operations segment covers all areas relating to the commercial sales and is being performed by the subsidiary in the U.S. The Research and Development segment includes the study and licensing of therapeutic candidates. Its products include Talicia, Movantik, and Aemcolo. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel.
Displays a symbol's price movements over previous years to identify recurring trends.